CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

SERA PROGNOSTICS, INC.

SERA
$51M
Micro Cap
NASDAQServices-Medical Laboratories🇺🇸North AmericaSALT LAKE CITY

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

SERA News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How SERA's past catalysts played out

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is SERA PROGNOSTICS, INC.'s next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for SERA PROGNOSTICS, INC. (SERA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track SERA biotech catalysts?

Add SERA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow SERA PROGNOSTICS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply